HighTide Therapeutics raises $107M to advance metabolic and digestive disease therapies


The company has multiple drugs in its pipeline but has not yet brought any to market.

Previous UC Health doctors update Buffalo Bills safety Damar Hamlin's recovery
Next Health care firm Herself Health raises $7M, opens inaugural St. Paul clinic